Lerner et al. found serum IgM antibodies to EBV-VCA in CFS patients but not in controls and recently reported elevated antibodies against EBV-dUTPase and EBV-DNA polymerase in a subset of CFS patients [39], [40]. This evidence concerns the gene CD40LG and myalgic encephalomeyelitis/chronic fatigue syndrome.